Recurrent chromosome aberrations in cancer

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Over 600 acquired, recurrent, balanced chromosome rearrangements identified in neoplastic cells over 25 years.
• Specific cytogenetic abnormalities can subdivide tumor types, aiding in diagnosis and prognosis.
• Nearly 100 genes are implicated in neoplasia-associated chromosomal rearrangements, predominantly in hematological disorders.

Purpose of the Study:

• To highlight the diagnostic and prognostic significance of cytogenetic abnormalities in cancer.
• To discuss the molecular mechanisms underlying chromosome rearrangements in neoplasia.
• To emphasize the clinical utility of cytogenetic analysis in cancer subclassification and treatment selection.

Main Methods:

• Review of cytogenetic investigations of neoplastic cells.
• Analysis of molecular mechanisms of balanced chromosome rearrangements.
• Evaluation of clinical data correlating cytogenetic abnormalities with diagnosis and prognosis.

Main Results:

• Established that every tumor type can be subdivided by specific chromosome abnormalities.
• Identified two primary molecular mechanisms: gene deregulation and hybrid gene creation.
• Demonstrated the clinical usefulness of cytogenetic abnormalities as diagnostic and prognostic aids, particularly in hematological neoplasms.

Conclusions:

• Recurring chromosome abnormalities are crucial for diagnosing, subclassifying, and selecting treatment for malignant diseases.
• Karyotype serves as an independent prognostic factor in cancer.
• Cytogenetic analysis is integral to the diagnostic work-up of hematological neoplasms, with expected advancements in solid tumors.